Evaluation of survivin expression in the endometrium and endometriotic lesions in patients with genital endometriosis, type 1 diabetes mellitus and their comorbidity

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

BACKGROUND: The prevalence of external genital endometriosis is high, yet there is insufficient understanding of its etiology and pathogenesis. This coupled with the challenges posed by its diagnosis and treatment, and its co-occurrence with type 1 diabetes mellitus, underscores the significance of this issue.

AIM: The aim of this study was to evaluate the expression of survivin in the eutopic endometrium, endometriotic lesions, and their concomitant conditions in patients with external genital endometriosis and type 1 diabetes mellitus.

MATERIALS AND METHODS: This study enrolled 43 female patients of reproductive age who were divided into four groups. The main group (n = 17) included women with surgically and histologically confirmed external genital endometriosis combined with type 1 diabetes mellitus. The external genital endometriosis group (n = 9) comprised women with isolated external genital endometriosis, while the type 1 diabetes mellitus group (n = 6) included patients with type 1 diabetes mellitus only. Finally, the control group (n = 6) consisted of women without any gynecological pathology. Biological specimens were collected during the follicular phase of the menstrual cycle, and morphological examination was carried out through histological and immunohistochemical evaluation of the endometrium and endometrioid heterotopias. Statistical analysis of the data was performed using the Jamovi software program, with statistical significance defined as p < 0.05.

RESULTS: Our findings indicate that patients with external genital endometriosis and comorbid type 1 diabetes mellitus exhibit a statistically significant increase in survivin expression in the endometrium compared to the control group or patients with type 1 diabetes mellitus only. However, no significant difference was observed in survivin expression in endometriotiс lesions between patients with external genital endometriosis and those with external genital endometriosis combined with type 1 diabetes mellitus.

CONCLUSIONS: The data obtained suggest the role of survivin in the pathogenesis of external genital endometriosis, regardless of the presence of type 1 diabetes mellitus.

Full Text

Restricted Access

About the authors

Nelly Yu. Andreeva

The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

Author for correspondence.
Email: nelly8352@yahoo.com
ORCID iD: 0000-0002-1928-1266
SPIN-code: 3355-2646

MD

Russian Federation, Saint Petersburg

Maria I. Yarmolinskaya

The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

Email: m.yarmolinskaya@gmail.com
ORCID iD: 0000-0002-6551-4147
SPIN-code: 3686-3605
Scopus Author ID: 7801562649
ResearcherId: P-2183-2014

MD, Dr. Sci. (Med.), Professor, Professor of the Russian Academy of Sciences

Russian Federation, Saint Petersburg

Elena V. Misharina

The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

Email: mishellena@gmail.com
ORCID iD: 0000-0002-0276-7112
SPIN-code: 7350-5674
Scopus Author ID: 57200069538
ResearcherId: K-2720-2018

MD, Cand. Sci. (Med.)

Russian Federation, Saint Petersburg

Gulrukhsor Kh. Tolibova

The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

Email: gulyatolibova@mail.ru
ORCID iD: 0000-0002-6216-6220
SPIN-code: 7544-4825
Scopus Author ID: 23111355700
ResearcherId: Y-6671-2018

MD, Dr. Sci. (Med)

Russian Federation, Saint Petersburg

Valeriia O. Semenova

The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

Email: pyankova.valeriia@rambler.ru
ORCID iD: 0000-0002-9101-1981
SPIN-code: 1422-8060
Scopus Author ID: 57863306500
ResearcherId: HKF-5961-2023

MD

Russian Federation, Saint Petersburg

References

  1. Yarmolinskaya MI. Ailamazyan EK. Genital endometriosis — different facets of the issue. Saint Petersburg: Eco-Vector; 2017. (In Russ.)
  2. Bulun SE, Yilmaz BD, Sison C, et al. Endometriosis. Endocr Rev. 2019;40(4):1048–1079. doi: 10.1210/er.2018-00242
  3. Shafrir AL, Farland LV, Shah DK, et al. Risk for and consequences of endometriosis: A critical epidemiologic review. Best Pract Res Clin Obstet Gynaecol. 2018;(51):1–15. doi: 10.1016/j.bpobgyn.2018.06.001
  4. Hemmert R, Schliep KC, Willis S, et al. Modifiable life style factors and risk for incident endometriosis. Paediatr Perinat Epidemiol. 2019;33(1):19–25. doi: 10.1111/ppe.12516
  5. Sinaii N, Cleary SD, Ballweg ML, et al. High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. Hum Reprod. 2002;17(10):2715–2724. doi: 10.1093/humrep/17.10.2715
  6. Mormile R, Vittori G. Type 1 diabetes in women with endometriosis: what is the risk of occurrence? J Pediatr Endocrinol Metab. 2013;26(9–10):1007–1008. doi: 10.1515/jpem-2013-0134
  7. Shafrir AL, Palmor MC, Fourquet J, et al. Co-occurrence of immune-mediated conditions and endometriosis among adolescents and adult women. Am J Reprod Immunol. 2021;86(1). doi: 10.1111/aji.13404
  8. Wu X, Zhang Q, Wang X, et al. Survivin is required for beta-cell mass expansion in the pancreatic duct-ligated mouse model. PLoS One. 2012;7(8). doi: 10.1371/journal.pone.0041976
  9. Misharina EV, Yarmolinskaya MI, Ivaschenko TE, et al. The role of survivin in the pathogenesis of genital endometriosis, current application possibilities (literature review). Gynecology. 2020;22(6):11–15. (In Russ.) doi: 10.26442/20795696.2020.6.200486
  10. Fujino K, Ueda M, Takehara M, et al. Transcriptional expression of survivin and its splice variants in endometriosis. Mol Hum Reprod. 2006;12(6):383–388. doi: 10.1093/molehr/gal042
  11. Watanabe A, Taniguchi F, Izawa M, et al. The role of survivin in the resistance of endometriotic stromal cells to drug-induced apoptosis. Hum reprod. 2009;24(12):3172–3179. doi: 10.1093/humrep/dep305
  12. Mori T, Ito F, Matsushima H, et al. G protein-coupled estrogen receptor 1 agonist G-1 induces cell cycle arrest in the mitotic phase, leading to apoptosis in endometriosis. Fertil Steril. 2015;103(5). doi: 10.1016/j.fertnstert.2015.01.026
  13. Konno R, Yamakawa H, Utsunomiya H, et al. Expression of survivin and Bcl-2 in the normal human endometrium. Mol Hum Reprod. 2000;6(6):529–534. doi: 10.1093/molehr/6.6.529
  14. Tarkowski R, Wojcierowski J, Polak G, et al. Ekspresja genu surviviny w prawidłowym i rozrostowym endometrium [Expression of the survivin gene in normal and hyperplastic endometrium]. Ginekol Pol. 2000;71(9):1226–1229.
  15. Lehner R, Enomoto T, McGregor JA, et al. Correlation of survivin mRNA detection with histologic diagnosis in normal endometrium and endometrial carcinoma. Acta Obstet Gynecol Scand. 2002;81(2):162–167. doi: 10.1034/j.1600-0412.2002.810213.x
  16. Nabilsi NH, Broaddus RR, McCampbell AS, et al. Sex hormone regulation of survivin gene expression. J Endocrinol. 2010;207(2):237–243. doi: 10.1677/JOE-10-0128
  17. Cho M, Lee OH, Chang EM, et al. BIRC5 expression is regulated in uterine epithelium during the estrous cycle. Genes. 2020;11(3). doi: 10.3390/genes11030282
  18. Erkanli S, Kayaselcuk F, Kuscu E, et al. Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium. Int J Gynecol Cancer. 2006;16(3):1412–1418. doi: 10.1111/j.1525-1438.2006.00541.x
  19. Vaskivuo TE, Stenbäck F, Karhumaa P, et al. Apoptosis and apoptosis-related proteins in human endometrium. Mol Cell Endocrinol. 2000;165(1–2):75–83. doi: 10.1016/s0303-7207(00)00261-6
  20. Bianco B, Filipchiuk C, Christofolini DM, et al. The role of survivin in the pathogenesis of endometriosis. Minerva Med. 2020;111(1):21–32. doi: 10.23736/S0026-4806.19.06358-4
  21. Zhang H, Li M, Zheng X, Sun Y, Wen Z, Zhao X. Endometriotic stromal cells lose the ability to regulate cell-survival signaling in endometrial epithelial cells in vitro. Mol Hum Reprod. 2009;15(10):653–663. doi: 10.1093/molehr/gap069
  22. Connell CM, Colnaghi R, Wheatley SP. Nuclear survivin has reduced stability and is not cytoprotective. J Biol Chem. 2008;283(6):3289–3296. doi: 10.1074/jbc.M704461200
  23. Stauber RH, Rabenhorst U, Rekik A, et al. Nucleocytoplasmic shuttling and the biological activity of mouse survivin are regulated by an active nuclear export signal. Traffic. 2006;7(11):1461–1472. doi: 10.1111/j.1600-0854.2006.00486.x
  24. Koninckx PR, Fernandes R, Ussia A, et al. Pathogenesis based diagnosis and treatment of endometriosis. Front Endocrinol. 2021;12. doi: 10.3389/fendo.2021.745548
  25. Zhu B, Qu S. The Relationship between diabetes mellitus and cancers and its underlying mechanisms. Front Endocrinol. 2022;13. doi: 10.3389/fendo.2022.800995

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Survivin expression in the eutopic endometrium in patients of the study groups. DM, type 1 diabetes mellitus; EGE, external genital endometriosis

Download (74KB)
3. Fig. 2. Survivin expression in the eutopic endometrium in patients of the study groups: a, external genital endometriosis; b, external genital endometriosis combined with type 1 diabetes mellitus; c, control; d, type 1 diabetes mellitus. Immunohistochemical study, zoom ×100

Download (504KB)
4. Fig. 3. Survivin expression in endometrioid heterotopias in patients of the study groups: a, external genital endometriosis; b, external genital endometriosis combined with type 1 diabetes mellitus. Immunohistochemical study, zoom ×400

Download (174KB)

Copyright (c) 2023 Eсо-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 66759 от 08.08.2016 г. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия Эл № 77 - 6389
от 15.07.2002 г.



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies